PIVLAZ Trademark

Trademark Overview

On Monday, June 12, 2006, a trademark application was filed for PIVLAZ with the United States Patent and Trademark Office. The USPTO has given the PIVLAZ trademark a serial number of 79025577. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, June 13, 2016. This trademark is owned by Actelion Pharmaceuticals Ltd.. The PIVLAZ trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS FOR CARDIOVASCULAR, PULMONARY, INFLAMMATORY INDICATIONS AS WELL AS FOR THE TREATMENT OF CANCER
pivlaz

General Information

Serial Number79025577
Word MarkPIVLAZ
Filing DateMonday, June 12, 2006
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, June 13, 2016
Registration Number3302805
Registration DateTuesday, October 2, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 17, 2007

Trademark Statements

Goods and ServicesPHARMACEUTICAL PREPARATIONS FOR CARDIOVASCULAR, PULMONARY, INFLAMMATORY INDICATIONS AS WELL AS FOR THE TREATMENT OF CANCER

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 9, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameActelion Pharmaceuticals Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH-4123 Allschwil
CH
Party NameActelion Pharmaceuticals Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH-4123 Allschwil
CH
Party NameActelion Pharmaceuticals Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH-4123 Allschwil
CH

Trademark Events

Event DateEvent Description
Friday, March 5, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, April 3, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, March 1, 2019REFUSAL PROCESSED BY IB
Friday, December 30, 2016NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, December 30, 2016DEATH OF INTERNATIONAL REGISTRATION
Friday, July 3, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, June 9, 2015TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, June 9, 2015INVALIDATION PROCESSED
Friday, January 9, 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, May 9, 2014CANCELLED SECTION 71
Thursday, May 30, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 29, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 29, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 19, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, January 16, 2008FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, January 16, 2008FINAL DISPOSITION PROCESSED
Wednesday, January 9, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 2, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, July 17, 2007PUBLISHED FOR OPPOSITION
Wednesday, June 27, 2007NOTICE OF PUBLICATION
Tuesday, May 1, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 30, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 23, 2007AMENDMENT FROM APPLICANT ENTERED
Monday, April 23, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 23, 2007ASSIGNED TO LIE
Monday, March 19, 2007PAPER RECEIVED
Friday, December 8, 2006REFUSAL PROCESSED BY IB
Wednesday, November 15, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, November 15, 2006REFUSAL PROCESSED BY MPU
Wednesday, November 15, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, November 14, 2006NON-FINAL ACTION WRITTEN
Monday, November 13, 2006ASSIGNED TO EXAMINER
Friday, August 11, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, August 10, 2006SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

pivlaz well treatment cancer indications inflammatory preparations cardiovascular pulmonary pharmaceutical